Hedge Fund Wagers Million on Biotech After FDA Milestone
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Understanding when index funds are worth it depends on time horizon and fees. This quick guide outlines key scenarios and considerations.
14,180 articlesA major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
Yields on the 10-year Treasury push toward a key 4.75% level as investors weigh dividend-growth strategies against hi...
As summer heat climbs, the strait hormuz still closed reshapes energy markets and portfolios. This guide translates r...
Gold resumes its ascent in 2026, with three ETFs offering distinct risk paths to access the metal. GLD, GLDM, and GDX...
A May 2026 poll defines a new voter cohort—the disillusioned—showing widespread financial strain and a belief that th...
This morning’s update centers on a massive Zcash exploit found by a security researcher. The flaw may have lingered f...
Berkshire Hathaway sits on a vast cash cushion, yet the hidden engine that fuels decades of growth runs deeper. This ...
Fortune unveils the Crypto 100, a comprehensive ranking of the most influential blockchain-focused firms. The list si...
Growing demand for aging-in-place technology is reshaping funding options for seniors. This report explains how rever...
A veteran hedge-fund manager behind an early SpaceX investment argues the AI-driven bottleneck trade is fading, trigg...
Choosing between an energy infrastructure ETF and a clean energy fund comes down to income versus growth and risk. Th...